Pharmaceuticals, Biotechnology and Life Sciences
— MGTA-145: Three Phase 2 clinical trials ongoing or planned to evaluate MGTA-145, a biologic used in combination with plerixafor…
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the 39th Annual…
Aviceda has assembled a renowned team of scientific entrepreneurs and biopharma senior executives to spearhead ongoing development efforts of pipeline…
Estimated $43.0M – $43.5M in Rubraca® (rucaparib) global sales for Q4 2020 and $164.2M – $164.7M for FY 2020 Q4/FY…
AXA1665 Phase 2 trial initiation planned for Q2 AXA1125 Phase 2b trial initiation planned for Q2 Company decides not to…
DUBLIN–(BUSINESS WIRE)–The “Artificial intelligence in Healthcare Global Market – Forecast To 2027” report has been added to ResearchAndMarkets.com’s offering. Artificial…
DUBLIN–(BUSINESS WIRE)–The “Global Microbiome Therapeutics Market: Focus on Target Therapies, Region (10 Countries), and Competitive Landscape – Analysis and Forecast,…
Shares Business Impact, Insights and Predictions for Patient-Centered Drug Development at JPM 2021 PALO ALTO, Calif.–(BUSINESS WIRE)–#biotech—Medable Inc, the leading…
– TOPAZ Phase 2 trial evaluating apitegromab in spinal muscular atrophy on-track to report top-line results from the 12-month treatment…
On Track to Initiate Three Clinical Trials in 2021 Across Franchise of Targeted Hematology Therapies, Including Phase 3 Trial for…